We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Vyriad

News List

Vyriad to Develop Antibody Test to Determine COVID-19 Protective Immunity americanpharmaceuticalreview
May 18, 2020
Vyriad has completed the development of a serology test to measure protective immunity against SARS-CoV-2, the novel coronavirus that causes COVID-19.
Vyriad Announces Collaboration with Merck KGaA and Pfizer to Evaluate Voyager-V1, Avelumab americanpharmaceuticalreview
July 24, 2018
Vyriad has announced a collaboration agreement with Merck KGaA, Darmstadt, Germany, and Pfizer to expand its ongoing Phase 1 clinical trial program in solid tumors to include a combination study of its lead asset, Voyager-V1, with avelumab, a human anti-P
Vyriad signs a contract with IBM to build an oncolytic virus anti-cancer vaccines manufacturing facility biospectrumasia
May 14, 2018
The custom buildout will be financed with proceeds from a recently completed $9 million secured convertible note financing...